1. Real-time oncology review (RTOR): guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2023 Subject(s): Biological ProductsDrug ApprovalDrug IndustryDrugs, InvestigationalGovernment RegulationNeoplasms -- drug therapyUnited States
2. Submitting patient-reported outcome data in cancer clinical trials: guidance for industry : technical specifications document Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, November 2023 Subject(s): Clinical Trials as TopicDrug DevelopmentDrug IndustryGovernment RegulationNeoplasms -- drug therapyPatient Reported Outcome MeasuresUnited States